Skip to main content
. 2017 Apr 19;152(4):327–335. doi: 10.1001/jamasurg.2016.4755

Table 1. Comparison of Preoperative and Intraoperative Variables Between Cohorts Undergoing OPD or RPD Before and After Propensity Score-Matching (Model 1).

Variable No. (%)
Before Propensity Score-Matching After Propensity Score-Matching
OPD RPD P Value OPD RPD P Value
Patients 2661 (93.5) 185 (6.5) 152 (50.0) 152 (50.0)
Gland texture <.001 >.99
Firm/hard 1305 (49.0) 61 (33.0) 58 (38.2) 58 (38.2)
Soft 1356 (51.0) 124 (67.0) 94 (61.8) 94 (61.8)
Pathologic findings of high-risk disease? .27 >.99
No, PDAC/pancreatitis 1405 (52.8) 90 (48.6) 81 (53.3) 81 (53.3)
Yes, other pathologic findings 1256 (47.2) 95 (51.4) 71 (46.7) 71 (46.7)
Pancreatic duct diameter, mm <.001 >.99
≥5 730 (27.4) 67 (36.2) 57 (37.5) 57 (37.5)
4 527 (19.8) 20 (10.8) 18 (11.8) 18 (11.8)
3 739 (27.8) 41 (22.2) 37 (24.3) 37 (24.3)
2 539 (20.3) 38 (20.5) 32 (21.1) 32 (21.1)
≤1 126 (4.7) 19 (10.3) 8 (5.3) 8 (5.3)
Intraoperative blood loss, mL <.001 >.99
≤400 1431 (53.8) 147 (79.5) 123 (80.9) 123 (80.9)
401-700 608 (22.8) 21 (11.4) 16 (10.5) 16 (10.5)
701-1000 287 (10.8) 9 (4.9) 7 (4.6) 7 (4.6)
>1000 335 (12.6) 8 (4.3) 6 (3.9) 6 (3.9)
Operative factors
Type of reconstruction .04 >.99
Pancreaticojejunostomy 2569 (96.5) 185 (100) 152 (100) 152 (100)
Pancreaticogastrostomy 91 (3.4) 0 0 0
None, occlusion 1 (0.04) 0 0 0
Intraoperative drain placement? <.001
No 205 (7.7) 0 0 0
Yes 2456 (92.3) 185 (100) 152 (100) 152 (100)
Transanastomotic stent placement? <.001 >.99
No 1500 (56.4) 9 (4.9) 9 (5.9) 9 (5.9)
Internal 548 (20.6) 176 (95.1) 143 (94.1) 143 (94.1)
External 613 (23.0) 0 0 0
Prophylactic octreotide? .001 >.99
No 1826 (68.6) 105 (56.8) 100 (65.8) 100 (65.8)
Yes 835 (31.4) 80 (43.2) 52 (34.2) 52 (34.2)

Abbreviations: OPD, open pancreatoduodenectomy; PDAC, pancreatic ductal adenocarcinoma; RPD, robotic pancreatoduodenectomy.